The Anti-Phospholipid screen is a quantitative immunoassay for the determination of IgG and / or IgM antibodies against phospholipides (cardiolipin, phosphatidyl-serine, -inositol, -ethanolamine, phosphatidic acid and β2-glycoprotein I) in human serum. The Anti-Phospholipid screen is intended as an aid in the diagnosis of anti-phospholipid antibody syndrome (APAS) in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.
4050 – Anti-Phospholipid screen
Autoimmunity, Diagnostics, ELISA
4050 – Anti-Phospholipid screen
Enzyme immunoassay for the quantitative determination of IgG and / or IgM antibodies against phospholipids in human serum
Available Downloads:
| Indication | Anti-phospholipid antibody syndrome (APAS) |
|---|---|
| Format | Microtiter plate coated purified human cardiolipin, bovine phosphatidyl-serine, -inositol, -ethanolamine, phosphatidic acid and human β2-glycoprotein I |
| Total incubation time | 105 min. |
| No. of determinations | 96 (89 x 1) + 5 x Calibrators + 2 x Controls |
Related products
-
3710 – GliaDea IgA
Enzyme immunoassay for the quantitative determination of IgA antibodies against deamidated gliadin in human serum
-
3900 – Anti-ASGPR
Enzyme immunoassay for the semi-quantitative determination of IgG antibodies against asialoglycoprotein receptor in human serum
-
8063 – CytoBead® ANCA
The CytoBead® ANCA is an immunofluorescence assay (IFA) for the qualitative and semi-quantitative determination of IgG antibodies in human serum against neutrophil cytoplasmic antigens (ANCA) and the glomerular basal membrane (GBM). The CytoBead® ANCA is is intended as an aid in the diagnosis of systemic vasculitis as well as autoimmune renal disorders in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.